Murine Model of CD40-activation of B cells

Overview

This video demonstrates the procedure of CD40-activation and expansion of murine B cells from splenocytes of C57BL/6 mice. These cells can serve as model antigen-presenting cells (APCs) to study the induction of immunity.

Key Study Components

Area of Science

• Immunology
• Cell Biology
• Transplantation Immunology

Background

• CD40-activated B cells can act as alternative APCs to dendritic cells.
• These cells are being explored for immunotherapeutic applications.
• Human CD40 B cells were initially generated from PBMCs.
• The methodology has been adapted for use in murine models.

Purpose of Study

• To demonstrate the generation of CD40-activated B cells from murine splenocytes.
• To explore their potential in inducing immune responses.
• To optimize the generation process for future applications.

Methods Used

• CD40 signaling and stimulation with IL-4 for B cell activation.
• Expansion of activated B cells over several weeks.
• Transfer of human B cell generation principles to murine models.
• Utilization of splenocytes from C57BL/6 mice.

Main Results

• Successful activation and expansion of murine B cells demonstrated.
• CD40-activated B cells showed potential as APCs.
• Methodology can be applied to study immune induction.
• Findings support further research into immunotherapeutic uses.

Conclusions

• CD40-activated B cells can serve as effective APCs in murine models.
• The study provides a framework for future immunology research.
• Optimized methods can enhance the understanding of immune responses.

Frequently Asked Questions